ViiV Healthcare has launched the ‘Hii Future 2026’ grant program in Spain, offering a total of 200,000 euros to support digital innovation projects focused on HIV care and treatment. The initiative is part of the company’s broader strategic platform designed to foster multidisciplinary collaboration across clinical, social, and community levels in addressing HIV as a chronic condition.
The funding opportunity targets innovative projects that leverage digital technologies to improve HIV prevention, treatment adherence, patient engagement, and healthcare delivery. According to ViiV Healthcare, the program aims to travel beyond traditional clinical research by integrating diverse stakeholders including people living with HIV, healthcare professionals, non-governmental organizations, and health system managers in the design and implementation of solutions.
Applications for the Hii Future 2026 grants are being accepted through an online portal managed by ViiV Healthcare Spain, with selected projects expected to receive financial support to develop and scale evidence-based digital tools. The initiative emphasizes scalability and real-world impact, seeking proposals that can be adapted across different healthcare settings and regional contexts within Spain’s national HIV strategy.
This grant program builds upon ViiV Healthcare’s existing commitments to HIV innovation in Europe, including previous funding rounds and collaborative frameworks aimed at improving quality of life for people living with HIV. The company states that Hii Future functions as an integrative platform that connects ongoing initiatives—such as its National Policy program—while enabling the structured inclusion of new collaborative projects grounded in scientific evidence and patient-centered design.
Prospective applicants are encouraged to consult the official Hii Future webpage for detailed eligibility criteria, application guidelines, and timelines. The submission process requires a clear outline of project objectives, methodology, expected outcomes, and plans for sustainability beyond the grant period. Evaluation will prioritize innovation, feasibility, potential for broad impact, and alignment with global HIV care standards.
As of the announcement date in April 2026, ViiV Healthcare has not disclosed the exact number of grants to be awarded or the maximum funding per project, though the total available sum is confirmed at 200,000 euros. Interested parties are advised to monitor the official ViiV Healthcare Spain website for updates on the selection process and announcements of successful applicants later in the year.
The launch of Hii Future 2026 reflects a growing emphasis within the pharmaceutical industry on supporting digital health innovations that address persistent challenges in HIV care, such as stigma, access to treatment, and long-term retention in care. By funding projects that combine technology with community-based approaches, ViiV Healthcare aims to contribute to international efforts to end the HIV epidemic as a public health threat by 2030, in line with UNAIDS targets.
For ongoing updates on the Hii Future initiative and related HIV innovation programs, readers can refer to ViiV Healthcare’s official communications channels and regional office publications. The company continues to engage with public health authorities, patient advocacy groups, and academic institutions to shape the future of HIV care through collaborative, innovation-driven models.